Skip to content
AwardedSpainGoodsFramework agreement

Acuerdo marco para suministro de medicamentos exclusivos de uso hospitalario.

Published
Published 25 February 2025

Overview

Acuerdo marco para suministro de medicamentos exclusivos de uso hospitalario con destino a las farmacias de los hospitales del servicio extremeño de salud, a adjudicar por procedimiento negociado sin publicidad.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Contract type
Framework agreement
Published
25 February 2025
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€3,902,547
Award date
21 February 2025
Winners
  • Alexion Pharma Spain S.A.
  • Bristol Myers Squibb, S.A.U.
  • Gilead Sciences, S.L.
  • Glaxosmithkline, S.A.
  • Janssen Cilag S.A.
  • Merck S.L.
  • Merck Sharp And Dohme de España S.A.
  • Novartis Farmaceutica S.A.
  • Pfizer S.L.
  • Roche Farma S.A.
  • Sanofi Aventis S.A.
  • Takeda Farmaceutica España S.A.
  • UCB Pharma S.A.
  • Vertex Pharmaceuticals Spain S.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    23 April 2025

  2. Contract Award Notice

    17 April 2025

  3. Contract Award Notice

    11 April 2025

  4. Contract Award Notice

    25 February 2025

Contracting authority

  • Dirección General de Planificación Económica

    Procuring entity

    Mérida, Spain

    ID_PLATAFORMA: 20994040143164

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.